12 Strategic Insights into the 2026 US Fetal Bovine Serum Market: Bioprocessing Demand, Synthetic Alternatives, and Regulatory Rigor
As of February 2026, the North American life sciences sector is experiencing a significant surge in high-fidelity biomanufacturing, with the US Fetal Bovine Serum Market remaining a cornerstone for advanced cell culture applications. Despite the gradual emergence of serum-free media, the unparalleled growth-promoting properties of fetal bovine serum (FBS) continue to make it...
0 Kommentare 0 Anteile 360 Ansichten